Literature DB >> 31613595

Triple-Input Molecular AND Logic Gates for Sensitive Detection of Multiple miRNAs.

Xiaoyi Ma1, Xifeng Chen1, Yuguo Tang1, Ruhong Yan2, Peng Miao1,3.   

Abstract

Abnormal miRNA expressions are closely related to the occurrence and development of cancers. It is of great significance to monitor miRNA expression levels for early diagnosis and therapy of the diseases. This study presents two independent colorimetric strategies for simultaneously monitoring multiple miRNAs based on cross-linking or non-cross-linking aggregations of gold nanoparticles (AuNPs). By introducing a Y shaped DNA structure and two types of DNA modified AuNPs, a triple-input DNA AND logic gate is facilely developed with the cross-linking aggregation of AuNPs as the signal output. To improve the sensitivity and shorten reaction time, the logic gate is modified by further employing a three DNA strands formed duplex and hybridization chain reaction. Non-cross-linking aggregation of AuNPs is used to evaluate the concentration of initial miRNA inputs. This strategy does not require DNA modification of AuNPs and ultrahigh sensitivity is achieved with the amplification of hybridization chain reaction. The present work may provide powerful tools for multiple miRNAs diagnostics and inspire further development of DNA based logic gates.

Entities:  

Keywords:  DNA logic gate; cross-linking aggregation; gold nanoparticles; miRNA; non-cross-linking aggregation

Mesh:

Substances:

Year:  2019        PMID: 31613595     DOI: 10.1021/acsami.9b16812

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  FeII 4L4 Tetrahedron-Assisted Three-Way Junction Probe for Multiple miRNA Detection.

Authors:  Chun-Yan Qu; Li-Sha Zhou; Li-Hong Shu; Qian Huang
Journal:  ACS Omega       Date:  2021-01-20

2.  Development of a neuron model based on DNAzyme regulation.

Authors:  Cong Chen; Ranfeng Wu; Bin Wang
Journal:  RSC Adv       Date:  2021-03-08       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.